日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants

SARS-CoV-2 Omicron (B.1.1.529) 变体及其亚变体中 D614G 突变的自然选择

期刊:Molecular Therapy-Nucleic Acids
影响因子:6.1
doi:10.1016/j.omtn.2023.01.013
Chakraborty, Chiranjib; Saha, Abinit; Bhattacharya, Manojit; Dhama, Kuldeep; Agoramoorthy, Govindasamy
SARS-CoV-2
发表日期：2023
文献求助 收藏

Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses

通过整合生物信息学揭示法匹拉韦-RTP与SARS-CoV-2 RdRp复合物的结构和分子相互作用图谱：为开发靶向SARS-CoV-2和其他病毒的有效药物提供见解

期刊:Journal of Infection and Public Health
影响因子:4
doi:10.1016/j.jiph.2023.05.010
Chakraborty, Chiranjib; Bhattacharya, Manojit; Saha, Abinit; Alshammari, Abdulrahman; Alharbi, Metab; Saikumar, G; Pal, Soumen; Dhama, Kuldeep; Lee, Sang-Soo
微生物学
SARS-CoV-2
发表日期：2023
文献求助 收藏

D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?

D614G 突变在 SARS-CoV-2 的所有 VOI 和 VOC 中均有发生：这是达尔文开创的正向选择的一部分吗？

期刊:Molecular Therapy-Nucleic Acids
影响因子:6.1
doi:10.1016/j.omtn.2021.07.011
Chakraborty, Chiranjib; Saha, Abinit; Sharma, Ashish Ranjan; Bhattacharya, Manojit; Lee, Sang-Soo; Agoramoorthy, Govindasamy
SARS-CoV-2
发表日期：2021
文献求助 收藏

Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential

环状RNA的最新研究进展：生物合成、性质、功能和治疗潜力

期刊:Molecular Therapy-Nucleic Acids
影响因子:6.1
doi:10.1016/j.omtn.2021.05.022
Sharma, Ashish Ranjan; Bhattacharya, Manojit; Bhakta, Swarnav; Saha, Abinit; Lee, Sang-Soo; Chakraborty, Chiranjib
发表日期：2021
文献求助 收藏

Response to: Status of Remdesivir: Not Yet Beyond Question!

回复：瑞德西韦的地位：尚未毫无疑问！

期刊:Archives of Medical Research
影响因子:3.4
doi:10.1016/j.arcmed.2020.09.005
Saha, Abinit; Sharma, Ashish Ranjan; Bhattacharya, Manojit; Sharma, Garima; Lee, Sang-Soo; Chakraborty, Chiranjib
发表日期：2021
文献求助 收藏

Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

瑞德西韦治疗新冠肺炎的可能分子机制：我们需要了解更多

期刊:Archives of Medical Research
影响因子:3.4
doi:10.1016/j.arcmed.2020.05.001
Saha, Abinit; Sharma, Ashish Ranjan; Bhattacharya, Manojit; Sharma, Garima; Lee, Sang-Soo; Chakraborty, Chiranjib
肺炎
新冠
微生物学
发表日期：2020
文献求助 收藏

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19

托珠单抗：治疗新冠肺炎细胞因子风暴综合征的一种治疗选择

期刊:Archives of Medical Research
影响因子:3.4
doi:10.1016/j.arcmed.2020.05.009
Saha, Abinit; Sharma, Ashish Ranjan; Bhattacharya, Manojit; Sharma, Garima; Lee, Sang-Soo; Chakraborty, Chiranjib
肺炎
新冠
微生物学
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏